Bispecific antibodies for use in the treatment of hematological malignancies

The present invention relates to novel methods for the treatment of hematological malignancies. In particular, the invention relates to the treatment of hematological malignancies using antibodies comprising a first binding moiety that is able to bind human CD1d and a second binding moiety that is a...

Full description

Saved in:
Bibliographic Details
Main Authors Parren, Paul Willem Henri Ida, De Gruijl, Tanja Denise, Kater, Arnon Philip, De Weerdt, Iris, Van Der Vliet, Johannes Jelle, Lameris, Roeland
Format Patent
LanguageEnglish
Published 03.09.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel methods for the treatment of hematological malignancies. In particular, the invention relates to the treatment of hematological malignancies using antibodies comprising a first binding moiety that is able to bind human CD1d and a second binding moiety that is able to bind the human Vγ9Vδ2-TCR.
Bibliography:Application Number: US201917277984